EyePoint, Inc., a company based in Watertown, Mass., disclosed on July 16, 2026, that it has issued non-statutory stock options to new employees as part of their inducement awards. These options were granted outside of the company's 2023 Long-Term Incentive Plan. EyePoint, Inc. is listed on the Nasdaq under the symbol EYPT and focuses on developing and marketing therapies to aid patients with serious retinal ailments. This move aligns with NASDAQ Listing Rule 5635(c)(4) regulations.